<DOC>
	<DOCNO>NCT02818673</DOCNO>
	<brief_summary>Refractory ascites indication liver transplantation , include ascites resistant , intractable diuretic therapy ( International Ascites Club ) . This definition partly subjective ; establish posteriori , follow diuretic therapy administration patient , include untoward effect prominent ; require prolonged follow-up . An early diagnosis refractory ascites would avoid give diuretic therapy patient fail identify rapidly candidate liver transplantation . Such diagnosis could do pharmacokinetic ( PK ) study radiolabeled albumin peritoneal cavity serum .</brief_summary>
	<brief_title>Refractory Ascitis Diagnosis Study Labelled Albumin Pharmacokinetics</brief_title>
	<detailed_description>Main objective : ass performance PK parameter ( transfer label albumin ) peritoneal vascular compartment , diagnosis refractory ascitis , patient cirrhosis abundant ascitis . Design : proof concept study . Interventional cross-sectional study Beaujon Hospital ( Clichy , France ) , 1 recruiting center 1 non recruiting center . Patients recruit Hepatology department ( Pr Valla ) PK exploration perform nuclear medicine department ( Pr Lebtahi ) Beaujon Hospital . Description intervention : diuretic treatment discontinuation 7 day exploration patient sensitive ascitis , 7 day refractory ascitis . The day exploration , patient come hospital stay lie position . One intra-veinous injection 0,015 megabecquerel ( MBq ) /Kg label human serum albumin ( Iode-125 ( 125-I ) , Séralb®CisBio ) , compliance market authorization , simultaneously one intra-peritoneal injection 200 MBq label albumin ( Technetium 99m ( 99m-Tc ) , Vasculocis® , Cisbio ) , off-label use . It follow 5 minute mobilization patient ( right leave lateral decubitus ) , scintigraphy perform use gamma-camera Symbia T2 ( Siemens® ) . Repeated blood ( 5 ml ) peritoneal ascitis ( 3 ml ) sample perform injection every 30 minute 6 hour ( catheter place ) . Diuretic treatment restart day PK exploration . Patients followed-up 1 month phone call ( collection adverse event ) . Measurements : radioactivity measurement 99m-Tc 125-I biological sample perform counter device nuclear medicine department ( Wizard 3000 , Packard® ) . Unidirectional transfer label albumin ( 125-I ) vascular compartment ( plasma-P ) peritoneal compartment ( ascitis-A ) ( TPA ) , Unidirectional transfer label albumin ( 99m-Tc ) peritoneal ( A ) vascular compartment ( P ) ( TAP ) , ratio TPA/TAP calculate measurement use Matlab®.The gold standard define diagnosis refractory ascitis perform inclusion . Statistical analysis : performance TAP , TPA , ratio TPA/TAP diagnosis refractory ascitis , compute use Receiver Operating Characteristic ( ROC ) curve . Number patient : 30 patient ( 15 patient refractory ascitis 15 patient sensitive untreatable ascitis ) include 24 month period ( 1 2 patient per month ) , followed-up 2 month . The PK exploration perform nuclear medicine department 4 week inclusion . Total length study 26 month .</detailed_description>
	<mesh_term>Ascites</mesh_term>
	<criteria>patient consult Hepatology department Beaujon Hospital age 18 80 year old cirrhosis due alcoholic and/or dysmetabolic and/or viral ( HBV HCV ) cause , pathologically clinically/biologically/radiologically proven . Volume ascitis &gt; 5 L , either sensible refractory diuretic drug accord IAC criterion infection 2 week prior inclusion ( suspected proven ) upper gastrointestinal bleeding du portal hypertension 2 week prior inclusion transjugular intrahepatic portosystemic shunt ( TIPS ) advance hepatocellular carcinoma hepatic transplantation unability stay lie 6 hour pregnancy / lactation renal deficiency ( creat . clearance &lt; 60ml/min ) cardiac deficiency ( ≥ New York Heart Association ( NYHA ) III ) myocardial infarction ( &lt; 3 month ) cause ascitis contraindication human albumin ( 125I ) vasculosis ( 99mTc ) component radiopharmaceutics health insurance coverage unability go hospital 1 day exam refuse consent study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>diagnostic performance</keyword>
	<keyword>ascites</keyword>
</DOC>